Grifols (Grifols) Accumulated Depreciation

: $0 Mil (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Grifols's quarterly accumulated depreciation declined from Dec. 2022 ($-2,207 Mil) to Jun. 2023 ($0 Mil) but then stayed the same from Jun. 2023 ($0 Mil) to Sep. 2023 ($0 Mil).

Grifols's annual accumulated depreciation increased from Dec. 2021 ($-2,016 Mil) to Dec. 2022 ($-2,207 Mil) and increased from Dec. 2022 ($-2,207 Mil) to Dec. 2023 ($-2,474 Mil).

Grifols Accumulated Depreciation Historical Data

The historical data trend for Grifols's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

-1,429.36

-1,655.82

-2,015.97

-2,207.04

-2,474.40

Grifols Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Accumulated Depreciation																-	-2,207.04	-	-	-2,474.40

Grifols Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Grifols Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Grifols's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Grifols (Grifols) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (OTCPK:GIKLY) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

GIFOF:USA GIFLF:USA GRFS:USA GRFP:Mexico GRFe:UK GRFPe:UK 0RDV:UK 0RDU:UK GRF.P:Spain GRF:Spain OZTA:Germany

Address

Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174

Website

https://www.grifols.com

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's biopharma business contributed 83% of sales in 2022. Grifols also has smaller segments including diagnostics and biosupplies. Diagnostics is roughly 10% of revenue following the Biotest acquisition.